A Case Study of the Treatment Strategies Employed to Cure a COVID-19 Patient with Multiple Infections Successfully

https://doi.org/10.28991/SciMedJ-2023-05-03-02
Q Angle COVID-19 Klebsiella Pneumoniae Enterococcus Faecalis Fungal Infection Case Report.

Authors

  • Reza Abniki Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan,, Iran, Islamic Republic of
  • Arezoo Pourdad Department of Infection Control, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan,, Iran, Islamic Republic of
  • Kiana Shirani Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan,, Iran, Islamic Republic of
  • Davood Mansury
    mansuryd@med.mui.ac.ir
    Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan,, Iran, Islamic Republic of
Vol. 5 No. 3 (2023): September
Research Articles

Downloads

The COVID-19 pandemic has given rise to new clinical challenges in healthcare settings. One of these challenges includes a heightened risk of secondary invasive bacterial and fungal infections, which have been associated with a notable mortality rate. We report a fatal case of a COVID-19 patient with two bacterial and one fungal infection successfully cured. A woman went to the hospital with fatigue, cough, chest and abdominal pain, nausea, and vomiting symptoms. She tested positive for COVID-19 and had underlying health conditions. She had a bacterial infection called Klebsiella Pneumoniae. The bacteria were resistant to many antibiotics, but colistin was effective. After 20 days in the ICU, she developed a fungal and Enterococcus faecalis(which was a Vancomycin-Resistant Enterococcus (VRE)) infection. The second bacteria were treated with linezolid. After 35 days in the hospital, she was discharged with no signs of infection. It is crucial to include proper bacterial screening and treatment when addressing COVID-19.

 

Doi: 10.28991/SciMedJ-2023-05-03-02

Full Text: PDF